About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory DLBCL
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Michael Schuster
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Michael Schuster
0 views
October 18, 2019
Comments
0
Login to view comments.
Click here to Login
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Aggressive B-cell Lymphoma
28:25
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DL…
Feat.
A. Younes
15:02
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Overview of CD19 Directed CAR-T in DLBCL: Tisagenleucel, Axicabtagen…
Feat.
D. Maloney
23:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…
Feat.
B. Santomasso
11:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Correlative Analyses of Cytokine Release Syndrome and Neurological E…
Feat.
J. Westin
07:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Plasmablastic Lymphoma: Survival Analysis of a SEER Database (2010-2…
Feat.
J. Florindez
08:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory D…
Feat.
M. Schuster
